Technology | March 06, 2015

Bracco Launches EmpowerCTA+ Contrast Injection System

Re-engineered device introduces touchscreen technology, saline advance for CT angiograph

March 6, 2015 — Bracco Imaging, through its business unit Bracco Injeneering SA, announced the availability of its EmpowerCTA+, an advanced engineering contrast injection system.

The EmpowerCTA+ has initially been launched in the United States then gradually in Europe, and it will be presented at the European Congress of Radiology (ECR), March 4-8 in Vienna, Austria.

The re-engineered device includes advanced touchscreen technology that enables technologists to customize the contrast injection experience right at the patient’s side with new enhancements, including real-time variable flow rates, saline advance and saline jump.

The saline advance function tests a patient’s patency and vein integrity while the saline jump feature minimizes the amount of contrast a patient receives. The injector’s patented extravasation detection accessory (EDA) provides additional safety and peace of mind for the technologist. In addition, its eGFR calculator simplifies calculations for kidney evaluation function prior to contrast delivery. The risk of air embolisms to the patient is reduced due to the system’s built-in tilt sensor and lock.

For more information: www.braccoimaging.com


Related Content

News | Contrast Media

August 17, 2023 — University of Missouri School of Medicine neurologist Adnan Qureshi, MD recently led a study that ...

Home August 17, 2023
Home
News | Contrast Media

July 3, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...

Home July 03, 2023
Home
News | Contrast Media

May 11, 2021 — The American Institute of Ultrasound in Medicine (AIUM) and the American Society of Echocardiography (ASE ...

Home May 11, 2021
Home
Technology | Contrast Media

July 15, 2019 — The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic ...

Home July 15, 2019
Home
Videos | Contrast Media

Sharon Mulvagh, M.D., FASE, FACC, FRCPC, professor of medicine, division of cardiology, Dalhousie University, Halifax ...

Home June 28, 2019
Home
Feature | Contrast Media | Dave Fornell, Editor

Iodine-based contrast agents used in computed tomography (CT) and catheter-based angiography have been implicated as a ...

Home May 31, 2019
Home
News | Contrast Media

May 9, 2019 — Osprey Medical announced the launch of DyeMINISH, a global patient registry to evaluate the ongoing safety ...

Home May 09, 2019
Home
News | Contrast Media

November 30, 2018 — VigiLanz and Cincinnati Children’s Hospital Medical Center recently announced a collaboration that ...

Home November 30, 2018
Home
News | Contrast Media

In February 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Maryland, to explore ...

Home September 12, 2018
Home
News | Contrast Media

January 19, 2018 — Ligand Pharmaceuticals Inc. announced initiation of a program to develop contrast agents with reduced ...

Home January 19, 2018
Home
Subscribe Now